. CA depleting agents have an opposite (i.e., motor inhibitory)effect [l, 31, 34, 35]. Several reports have suggested the existence of a third functional CA neurotransmitter in the CNS. The biosynthetic enzyme for epinephrine (E) has been localized in hindbrain cell bodies [10, 19, 27] and both cell bodies and terminal varicosities have been visualized through immunohistofluorescent microscopy 110,14]. Also, epinephrine itself has been demonstrated centrally [2] . Relatively few studies have specifically addressed the role of E in motor activity.
THE CATECHOLAMINES ICA), norepinephrine (NE} and dopamine IDA) are known to play critical roles in motor integration and psychomotor activation. For example, I-DOPA (1-dihydroxyphenylalanine), the precursor to CA, produces a syndrome of motor activation after systemic injection [321 and central stimulation of NE and DA postsynaptic receptors increases motor activity [3, 13, 15, 16.21, 23, 29, 34, 351 . CA depleting agents have an opposite (i.e., motor inhibitory)effect [l, 31, 34, 35] . Several reports have suggested the existence of a third functional CA neurotransmitter in the CNS. The biosynthetic enzyme for epinephrine (E) has been localized in hindbrain cell bodies [10, 19, 27] and both cell bodies and terminal varicosities have been visualized through immunohistofluorescent microscopy 110,14]. Also, epinephrine itself has been demonstrated centrally [2] . Relatively few studies have specifically addressed the role of E in motor activity.
Several studies dating from the early part of the century reported sedation, depression, and stupor after central E administration (summarized in 1221). However, these studies invariably employed physiologically supranormal amounts of transmitter; more recent studies using lower doses and improved infusion techniques suggest E neurons may be motor excitatory [5, 12, 23] , note however I I I]. If E neurons are necessary for motor activity, it follows that inhibition of E synthesis should cause motor depression. In a preliminary communication we reported that inhibitors of PNMT, the synthesizing enzyme for E, produced an acute lowering of spontaneous motor activity 117]. The present experiments extend these observations by testing two inhibitors of brain PNMT for their effects on open field behavior.
METHOD

A nimals
Ninety adult ma~e Sprague-Dawley rats (20~275 g) (Charles River, Portage, MI) randomly chosen from our colony were used for behavioral testing. An additional 23 rats were used for biochemical determinations. All animals were maintained upon ad fib food ITeklad 4.0% fat diet S-0836) and water, and automatically programmed 12 hr light/12 hr dark cycles.
Apparatlt,~
Animals were tested in a 1. ployed in the present design [ 18] . Other studies have shown the latter to be free of effects upon monoamine oxidase or catechol-o-methyltransferase at the doses presently employed 1181. It should be noted that based upon studies in our laboratory of the dose response relationship of these compounds (Turner e: al., in preparation), the low and high doses of each drug were chosen to produce equivalent enzyme inhibition across compounds.
BehaHoral Procedure
One hour after initial injection of drug or vehicle animals were individually placed in the open field. Except for the actual transportation of animals from their cages to the open field, this was the only handling they experienced during the experiment. Grid crossings, rearings, and defecation were recorded for 4 consecutive 3 min periods. All animals from all conditions were tested on more than 1 occasion and received each treatment. However, a minimum of 48 hr intervened between any repeated tesls. Repeated testing produced (equivalent) lowering of initial activity across conditions.
Hiochentictd Procedure
At 1 hr animals matched for drug treatment, weight, and supplier with behaviorally tested animals were sacrificed by decapitation. Brains were removed and dissected upon a chilled glass plate. A 5 × 8 mm rectangular punch was used to standardize dissection of the pons-medulla which includes the C, and C~ adrenergic nuclei as defined by Hokfelt et ./.
[141. Brain tissue was immediately frozen in liquid nitrogen and stored at -30°C prior to assay. PNMT was assayed according to the procedure of Pendleton 1241 with several modifications including the use of :~H-methyI-Sadenosylmethionine (New England Nuclear Corp.) as the methyl donor together with unlabelled carder and the eliminalion of acid extraction of the labelled product. Triplicate determinations were performed on all samples. Proteins were measured by the method of Lowry 1201. Additional details of the assay procedure have been published elsewhere 1331.
Stati,~tic,~
All comparisons were by Analysis of Variance. All results are presented as mean and standard error. Analysis of variance was by a two-factor mixed design ANOVA with repeated measures on one factor 161. Factors analyzed were dosage and time, and the BMOD2Y program for analysis of variance of the health sciences computing facility of the University of California was used for the actual analyses. Individual analyses were performed for each behavior. Also. randomized design ANOVA was used for defecation scores.
RESULTS
Biochemical results. The PNMT inhibitors each reduced central enzyme activity in a dose related manner. DCMB (12.5 mg/kg) and SKF 64139 (10 mg/kg) produced 48cA and 47cA inhibition in comparison to control animals and DCMB (25.0 mg/kg) and 64139 (40 mg/kg) produced 60 and 62~ inhibition in comparison to control animals. Actual brainstem activity for control animals was 37.0 +_ 3 picomoles/l mg protein~hr. All other actual values may be calculated from this.
BehaHoral re,suits. Following injection informal observations of animals over the 1 hr preceding behavioral testing indicated virtually all (=:Sfr'Z.) experimental animals engaged in vigorous stereotyped sniffing and gnawing of the wood bedding of their cages. Few (-:: 1(~.) control animals showed this behavior, and no other behavioral changes were obvious in the observation period. This change in behavior has been observed previously 1171. In the present design drug treated animals continued to show high levels of sniffing during experimental observations. Gnawing and biting and repetitive motor activity were not observed however it must be noted that the open field was a fiat surface, and typically lacked objects with which these behaviors could be expressed.
Effects of these drugs upon motor activity (grid crossings), rearing, and defecation are presented in Figs. I, 2 and 3. In Fig. 1 , a dose related decrease in ambulation was found for both compounds. Effects of both drugs and session interval were significant, F(4,85) drug-14. I. p-0.001: F(3,255) session interval -13.25, p-0.001. while there was no significant interaction between these variables. F(12,255) 1.6, p -0.1. Moreover, equivalent amounts of PNMT inhibition produced similar behavioral effects. 112,231 as well as with our own earlier observations 1171 in rats. Adrenergic stimulation has previously been shown to increase motor activity and we have shown an acute lowering of activity after adrenergic inhibition. Observations upon behavioral depression after yohimbine, a blocker of adrenergic sensitive adenyl cyclase [9, 36] also support a role for epinephrine in the facilitation of motor behavior. A variety of different experiments using adrenergic stimulation and inhibition therefore suggest a facilitatory role for E in motor behavior. Our specific findings of decreased ambulation and rearing and possibly increased stereotypy suggest that adrenergic systems normally facilitate exploration but inhibit stereotypy. Clearly an assessment of drug effects upon activity must carefully account for the testing paradigm employed, and in the present circumstances we emphasize two separate sets of behavioral observations. The similarity of behavioral changes after different drug treatments which produced similar changes in brain PNMT further supports this system as the mediator of the two observed behavioral syndromes. It would appear from our results that adrenergic systems do participate in the control of motor activity. This might also be expected in part from studies reporting moderate PNMT concentrations in areas associated with motor control, e.g., within the substantia nigra and basal ganglia 1191. Low but measurable amounts of enzyme have also been reported in other CNS areas associated with motor control, e.g., in the cerebellum and red nucleus of several primate species, including man [ 19] .
We feel that two interpretations of the changes in open field behavior are possible. By the first, the action of E is direct, e.g., as a necessary component of a final common path for behavioral expression. The second interpretation assigns a modulatory role to E, i.e., E containing neurons may affect another system which in turn controls motor activity. The present findings are consistent with either interpretation. However, we feel particular attention should be paid to the latter. On the one hand previous histochemical findings do not report Epi in motor neurons. Moreover, behavioral and anatomical evidence are consistent with an indirect mode of action. We have pointed out that E, in fact, innervates DA containing areas of the extrapyramidal motor system, as well as other motor areas. Our findings suggest an increase in stereotyped sniffing and gnawing after PNMT inhibition. It is possible E governs DA systems by exerting a tonic inhibition upon them. While it is not clear that motor inhibition and stereotypy are always or necessarily inimical at a behavioral level, a number of experiments (e.g., 126,30D suggest cases of DA mediated stereotypy may be characterized by relative decreases in ambulation and rearing. Certainly, this is consistent with our findings.
It might also be noted that PNMT inhibition facilitates other stereotyped behaviors which are DA mediated at least in part 117]. Perhaps the most direct evidence for this may be found in recent preliminary observations from our laboratory, that adrenergic inhibition facilitated DA dependent DOPA induced behaviors. While continued investigations of the neural systems involved is necessary, our results do suggest a behavioral significance for adrenergic systems and a possible relation to DA.
